PlatformsAustralian Brain Bank Network (ABBN)

2005

Aoki-Suzuki M, Yamada K, Meerabux J, Iwayama-Shigeno Y,Ohba H, Iwamoto K, Takao H, Toyota T, Suto Y, Nakatani N, Dean B, Nishimura S, Seki K, Kato T, Itohara S, Nishikawa T, Yoshikawa T. (2005) A Family-Based Association Study and Gene Expression Analyses of Netrin-G1 and -G2 Genes in Schizophrenia. Biological Psychiatry 57: 382-393

Broe M, Shepherd CE, Mann DM, Milward EA, Gai WP, Thiel E, Halliday GM. (2005). Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation. Neurotox Res. 7(1-2):69-76.

Cai Z, Manavis J, Cash K, Thompson PD, Blumbergs PC. (2005) Immunohistochemical staining of epoxy resin sections of peripheral nerve. Appl Immunohistochem Mol Morphol 13(3):292-4

Cappai R, Leck SL, Tew DJ, Williamson NA, Smith DP, Galatis D, Sharples RA, Curtain CC, Ali FE, Cherny RA, Culvenor JG, Bottomley SP, Masters CL, Barnham KJ, Hill AF. (2005). Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J.

Crews FT, Buckley ST, Dodd PR, Ende G, Foley PF, Harper CG, He J, Innes DJ, Loh E-W, Pfefferbaum A, Zou J, Sullivan EV. (2005) Alcoholic neurobiology: changes in dependence and recovery. Alcohol. Clin. Exper. Res. 29, 1504-1513.

Crouch PJ, Blake R, Duce JA, Ciccotosto GD, Li QX, Barnham KJ, Curtain CC, Cherny RA, Cappai R, Dyrks T, Masters CL, Trounce IA. (2005). Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci. ;25(3):672-9.

Dean B, Keriakous D, Thomas E, Scarr E. (2005) Understanding the pathology of schizophrenia: The impact of high-throughput screening of the genome and proteome in postmortem CNS. Current Psychiatry Reviews 1: 1-9.

Dean B, Scarr E, McLeod M. (2005) Changes in hippocampal GABAA receptor sub-unit composition in bipolar 1 disorder. Molecular Brain Research 138: 145-155.

Digney AL., Keriakous D, Scarr E, Thomas EA, Dean B. (2005) Differential changes in apolipoprotein E in schizophrenia and bipolar 1 disorder. Biological Psychiatry 57: 711-715.

Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. (2005). Distribution of the Vitamin D receptor and 1 -hydroxylase in human brain. J Chem Neuroanat. 29; 21-30.

Federow H, Halliday GM, Rickert C, Gerlach M, Riederer P, Double KL. (2005). Evidence for specific phases in the development of human neuromelanin: implications for dopamine cellular function and metabolism. Neurobiol Aging (online).

Federow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL. (2005) Neuromelanin in human dopamine neurons:comparison with peripheral melanins and relevance to Parkinson's disease. (Review). Prog Neurobiol. 75: 109-124.

Flatscher-Bader T, van der Brug M, Hwang J, Gochee P, Matsumoto I, Niwa S, Wilce P. (2005). Alcohol-responsive genes in the frontal cortex and nucleus accumbens of human alcoholics. J Neurochem 2005 93; 359-370. Erratum published online.

Gibson J, Williamson S, Arbuckle S, Christodoulou J. (2005). X chromosome inactivation patterns of the brain in Rett syndrome: implications for the disease phenotype. Brain Dev, 27; 266-270.

Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J (2005) Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 128: 597-605.

Guillemin GJ, Brew BJ, Noonan C, Takikawa O, Cullen K. (2005). Indoleamine 2,3 dioxygenase and quinolinic acid in plaque and neurons in post-mortem brain tissue from Alzheimer's disease and control cases. Neuropathol Appl Neurobiol (online).

Guillemin GJ, Smythe G, Takikawa O, Brew BJ (2005) Expression of indoleamine 2,3 dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons. Glia. 49: 15-23.

Harper C and Matsumoto I. (2005). Ethanol and brain damage. Curr Opin Pharmacol., 5; 73-78.

Jones AL, Mowry BJ, Pender MP, Greer JM. (2005) Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol. 83: 9-17.

Lawson VA, Collins SJ, Masters CL, Hill AF. (2005). Prion protein glycosylation. J Neurochem. 93(4): 793-801.

Lewohl JM, Wixey J, Harper CG ,Dodd PR (2005) Expression of MBP, PLP, MAG, CNP and GFAP in the human alcoholic brain. Alcohol. Clin. Exper. Res. 29, 1698-1705.

Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, Jensen PH. (2005). p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem.;280(7):5703-15.

Masayuki I, Depaz, Wilce P, Suzuki T, Niwa S, Matsumoto I. (2005). Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia. Neuroscience Letters. Vol 378; 125-130

Matsumoto I, Inoue Y, Iwazaki, T, Pavey G, Dean B. (2005) 5-HT2A and muscarinic receptors in schizophrenia: a post mortem study. Neuroscience Letters. 379: 164-168.

Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX. (2005). Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol. 86(3):147-59.

Noda K, Kitami T, Gai WP, Chegini F, Jensen PH, Fujimura T, Murayama K, Tanaka K, Mizuno Y, Hattori N. (2005). Phosphorylated IkappaBalpha is a component of Lewy body of Parkinson's disease. Biochem Biophys Res Commun. ;331(1):309-17.

Pamphlett R, King N, Kum Jew S. (2005). Flaviviruses in motor neuron disease. Muscle Nerve. , 32; 108-109.

Panegyres PK, Kwok JB, Schofield PR, Blumbergs PC. (2005) A Western Australian kindred with Dutch cerebral amyloid angiopathy. J Neurol Sci. 239(1):75-80.

Pountney DL, Chegini F, Shen X, Blumbergs PC, Gai WP.(2005). SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci Lett. 2005 Jun 10-17;381(1-2):74-9.

Pountney DL, Treweek TM, Chataway T, Huang Y, Chegini F, Blumbergs PC, Raftery MJ, Gai WP. (2005). Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. Neurotox Res.;7(1-2):77-85.

Pountney DL, Voelcker NH, Gai WP.(2005). Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis. Neurotox Res. ;7(1-2):59-67. Review.

Quilty MC, King AE, Gai WP, Pountney DL, West AK, Vickers JC, Dickson TC. (2005) Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection. Exp Neurol.; [Epub ahead of print]

Ryabinin AE, Tsivkovskaia NO, Ryabinin SA (2005) Urocortin 1-containing neurons in the human Edinger-Westphal nucleus. Neuroscience. 134; 1317-1323.

Scarr E, Beneyto M, Meadow-Woodruff JH, Dean B. (2005) Cortical glutamatergic markers in schizophrenia. Neuropsychopharmacol. 30: 1521-1532.

Short CL, Scott G, Blumbergs PC, Koblar SA. (2005) A case of presumptive primary lateral sclerosis with upper and lower motor neurone pathology. J Clin Neurosci;12(6):706-9.

Sundram S, Copolov DL, Dean B. (2005) Clozapine decreases [3H]CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens. Naunyn-Schmiedeberg's Archives of Pharmacology 371: 428-433.

Tsai VW-W, Dodd P, Lewis RJ. (2005). The effects of alanine-substituted conantokin-G and ifenprodil on the human spermine-activated N-methyl D-aspartate receptor. Neuroscience 130, 457-464.

Tsai VW-W, Scott HL, Lewis RJ, Dodd PR. (2005). The rôle of Group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease. Neurotox. Res. 7, 125-141.

Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL. (2005). Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease. J Clin Neurosci. ; 12(3):221-30.

Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD; Nomenclature Committee of the International Society of Amyloidosis. (2005) Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid;12(1):1-4. Review.

Williams SM, Sullivan RKP, Scott HL, Finkelstein DI, Colditz PB, Lingwood BE, Dodd PR, Pow DV. (2005). Glial glutamate transporter expression patterns in brains from multiple mammalian species. Glia 49, 520-541.

Al-Housseini AM, Dodd PR, Gu Q. (2005) Upregulation of -catenin in superior frontal cortex of chronic alcoholics. Soc. Neurosci. Abstr. Viewer, 798.9.

Bergeson SE, Berman AE, Dodd PR, Edenberg HJ, Hitzemann RJ, Lewohl JM, Lodowski KH, Sommer W. (2005) Expression profiling in alcoholism research. Alcohol. Clin. Exp. Res. 29, 1066-1073.

Chen T, Ajami K, McCaughan GW, Gai WP, Gorrell MD, Abbott CA. (2005) Molecular characterization of a novel dipeptidyl peptidase like 2-short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activity. Biochim Biophys Acta.;1764(1):33-43.

Cullen KM, Kocsi Z, Stone J. (2005) Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J Cereb Blood Flow Metab. ;25(12):1656-67.

Depaz IM, de Las Heras R, Kroon PA, Wilce PA. (2005) Changes in neuronal protein 22 expression and cytoskeletal association in the alcohol-dependent and withdrawn rat brain. J Neurosci Res. 81: 253-260.

Dickson, T.C., Chuckowree, J.A., Chuah, M.I., West, A.K. and Vickers, J.C. (2005) Alpha-internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury. Neurobiology of Disease 18, 286-295

Dodd PR, Foley PF, Buckley ST, Eckert AL, Innes DJ. (2005) The effect of genotype on receptor expression in human alcoholic brain. J. Neurochem. 94 Suppl. 2, 136.

Foley PF, Loh E-W, Innes DJ, Williams SM, Shen Y, Tannenberg AEG, Harper CG, Dodd PR. (2005) Combined influence of neurotransmitter gene polymorphisms in post-mortem alcoholics. Proc. Aust. Neurosci. Soc. 16, 34.

Guerrini I, Thomson A, Cook CCh, McQuillin A, Sharma V, Kopelman M, Reynolds G, Jauhar P, Harper C, Gurling HMD (2005) Direct genomic PCR sequencing of the high affinity thiamine transporter (SLC19A2) gene identifies three genetic variants in Wernicke Korsakoff Syndrome (WKS) Am J Med Genet B, Neuropsychiatr Genet 137B: 17:19.

Harper C, Matsumoto I, Pfefferbaum A, Adalsteinsson E, Sullivan E, Lewohl J, Dodd P, Taylor M, Fein G, Landman B. (2005) The pathophysiology of 'brain shrinkage' in alcoholics-structural and molecular changes and clinical implications. Alcohol Clin Exp Res. 29: 1106-1115.

Harper CG, Matsumoto I. Pfefferbaum A. Adalsteinsson E, Sullivan E, Lewohl JM, Dodd PR, Taylor M, Fein G Landman B. (2005) The pathophysiology of 'brain shrinkage' in alcoholics - structural and molecular changes and clinical implications. Alcohol. Clin. Exp. Res. 29, 1106-1115.

Kuo SW, Dodd PR. (2005) Stimulus-coupled amino acid transmitter release in human alcoholics. Proc. Aust. Neurosci. Soc. 16, 33.

Matsumoto I, Ikemoto K, Ito M, Inoue Y, Iwazaki T, Kunii Y, Shibata I, Yoh K, Wada A, Niwa S. (2005) Psychiatric Brain Bank: Establishment of systematic brain bank in Japan, Clin Psychiatry, 47: 559-567.

Newell KA, Zavitsanou K, and Huang XF. (2005) Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients. NeuroReport. 16: 1363-1367.

Walton HS, Pow DV, Innes DJ, Dodd PR. (2005) Isolation and identification of excitatory amino acid transporter-2 isoforms. Proc. Aust. Neurosci. Soc. 16, 80.

Walton HS, Pow DV, Innes DJ, Dodd PR. (2005) Proteomic analysis of excitatory amino acid transporter-2 isoforms in Alzheimer's disease. J. Neurochem. 94 Suppl. 2, 198.